The increase of mean serum levels of MMP-9 (Figure 4B) was statistically significant in stage III adenocarcinoma patients and was also found to be significantly correlated with increased serum levels of IL-8 of CRC at stage III. The gene discussed is CXCL8; the disease is adenocarcinoma.